Heydoc Raises $8.3M Series A to Enhance Patient Platform

Heydoc Secures $8.3 Million in Series A Funding

Heydoc, a platform designed to streamline medical data management and administrative processes for medical practitioners, has successfully completed an $8.3 million Series A funding round.

Smedvig Capital spearheaded the investment, with participation from existing investors including Hambro Perks, Triple Point Ventures, and InHealth Ventures.

This latest funding round increases the total capital raised by Heydoc to $12 million.

Market Position and Expansion Plans

Currently, Heydoc’s primary market is the U.K., but the company intends to pursue international expansion in the near future.

The platform primarily challenges established, traditional systems currently utilized by healthcare professionals and clinicians.

A key differentiator is Heydoc’s focus; while Medefer largely serves the NHS, Heydoc concentrates on private hospitals and clinics.

Furthermore, Heydoc facilitates connections between its clinic clients and a diverse network of healthcare providers, such as hospital groups, pathology services, and pharmacies.

Company Background and Pandemic Adaptation

Established in 2018, Heydoc was co-founded by Christoph Lippuner and Mikael Landau.

The company demonstrated adaptability during the pandemic, successfully transitioning to support remote consultations.

This transition allowed Heydoc to benefit from the increasing adoption of cloud-based workflow solutions within the healthcare sector.

Statements from Leadership

Christoph Lippuner, co-founder and CEO of Heydoc, stated that the new funding will be allocated to accelerating growth within the U.K.

He also emphasized the company’s commitment to product development, capability expansion, and entry into new international markets.

Jon Lerner, Managing Director at Smedvig Capital, commented on Heydoc’s rapid growth and its demonstrated ability to significantly enhance clinical workflows and patient engagement.